United States CDC announces an HPV vaccine recall

The United States Centers for Disease Control and Prevention (CDC) was informed by Merck on Monday that the pharmaceutical company planned to recall one lot of Gardasil [Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine, Recombinant].

The CDC media statement released yesterday states that the recall is because a number of vials may contain glass particles as a result of breakage during the vaccine manufacturing process.

Merck estimates that approximately ten of the 743,360 vials in the affected lot J007354 could have glass particles in them. The vaccines from the affected lot were distributed between August 20, 2013, and October 9, 2013.

If a vaccine containing glass particles is given to a patient, reactions at the injection site routinely seen after vaccination may occur. Physicians should report any adverse events following vaccination to the Vaccine Adverse Event Reporting System (VAERS).

###

By Jeannie Stokowski-Bisanti

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

New biomarkers may influence drug design and alternative treatments of cancer, study shows   UGA ecologist finds another cause of antibiotic resistance   Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy   Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy   New drug for neuroblastoma shows promise in phase I study   Experimental treatment sends deadly leukemia into remission   Study could reduce unnecessary cancer screening   UA researchers discover component of cinnamon prevents colorectal cancer in mice   Profiling approach to enable right lung cancer treatment match   Baclofen shows promise in patients with alcohol-induced liver disease   Fat grafting technique improves results of breast augmentation   Germline TP53 mutations in patients with early-onset colorectal cancer